Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D02CYQ
|
|||
Former ID |
DNC003609
|
|||
Drug Name |
2-Hydroxycarbamoyl-pentanedioic acid
|
|||
Synonyms |
2-Hydroxycarbamoyl-pentanedioic acid; CHEMBL432726; SCHEMBL13996815; BDBM50129193; 2-(Hydroxycarbamoyl)pentanedioic acid
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C6H9NO6
|
|||
Canonical SMILES |
C(CC(=O)O)C(C(=O)NO)C(=O)O
|
|||
InChI |
1S/C6H9NO6/c8-4(9)2-1-3(6(11)12)5(10)7-13/h3,13H,1-2H2,(H,7,10)(H,8,9)(H,11,12)
|
|||
InChIKey |
FSDICXJFWIWOEV-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Glutamate carboxypeptidase II (GCPII) | Target Info | Inhibitor | [1] |
KEGG Pathway | Alanine, aspartate and glutamate metabolism | |||
Metabolic pathways | ||||
Vitamin digestion and absorption | ||||
NetPath Pathway | TCR Signaling Pathway | |||
TNFalpha Signaling Pathway | ||||
Reactome | Amino acid synthesis and interconversion (transamination) | |||
WikiPathways | One Carbon Metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and biological evaluation of hydroxamate-Based inhibitors of glutamate carboxypeptidase II. Bioorg Med Chem Lett. 2003 Jul 7;13(13):2097-100. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.